NeueHealth Performance
| NEUEDelisted Stock | 6.75 0.05 0.74% |
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and NeueHealth are completely uncorrelated. NeueHealth right now secures a risk of 0.0%. Please verify NeueHealth daily balance of power and period momentum indicator , to decide if NeueHealth will be following its current price movements.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days NeueHealth has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, NeueHealth is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 375.3 M | |
| Total Cashflows From Investing Activities | 186.9 M | |
| Free Cash Flow | -125.5 M |
NeueHealth |
NeueHealth Relative Risk vs. Return Landscape
If you would invest 675.00 in NeueHealth on October 16, 2025 and sell it today you would earn a total of 0.00 from holding NeueHealth or generate 0.0% return on investment over 90 days. NeueHealth is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than NeueHealth, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
NeueHealth Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for NeueHealth's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as NeueHealth, and traders can use it to determine the average amount a NeueHealth's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| NEUE |
Based on monthly moving average NeueHealth is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NeueHealth by adding NeueHealth to a well-diversified portfolio.
NeueHealth Fundamentals Growth
NeueHealth Stock prices reflect investors' perceptions of the future prospects and financial health of NeueHealth, and NeueHealth fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on NeueHealth Stock performance.
| Return On Equity | -1.83 | |||
| Return On Asset | -0.0196 | |||
| Profit Margin | (0.09) % | |||
| Operating Margin | 0.07 % | |||
| Current Valuation | 1.05 B | |||
| Shares Outstanding | 9.02 M | |||
| Price To Sales | 0.07 X | |||
| Revenue | 936.66 M | |||
| EBITDA | (65.11 M) | |||
| Total Debt | 204.61 M | |||
| Book Value Per Share | (152.26) X | |||
| Cash Flow From Operations | (123.22 M) | |||
| Earnings Per Share | (17.65) X | |||
| Total Asset | 544.38 M | |||
| Retained Earnings | (4.44 B) | |||
About NeueHealth Performance
By analyzing NeueHealth's fundamental ratios, stakeholders can gain valuable insights into NeueHealth's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if NeueHealth has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if NeueHealth has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about NeueHealth performance evaluation
Checking the ongoing alerts about NeueHealth for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for NeueHealth help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| NeueHealth is not yet fully synchronised with the market data | |
| NeueHealth has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 936.66 M. Net Loss for the year was (99.72 M) with profit before overhead, payroll, taxes, and interest of 215.55 M. | |
| NeueHealth generates negative cash flow from operations | |
| About 58.0% of the company shares are owned by institutional investors |
- Analyzing NeueHealth's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NeueHealth's stock is overvalued or undervalued compared to its peers.
- Examining NeueHealth's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating NeueHealth's management team can have a significant impact on its success or failure. Reviewing the track record and experience of NeueHealth's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of NeueHealth's stock. These opinions can provide insight into NeueHealth's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private. You can also try the AI Portfolio Prophet module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in NeueHealth Stock
If you are still planning to invest in NeueHealth check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NeueHealth's history and understand the potential risks before investing.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |